Beone Medicines
Clinical trials sponsored by Beone Medicines, explained in plain language.
-
New hope for advanced breast cancer: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new drug, BGB-43395, combined with letrozole against standard CDK4/6 inhibitor combinations in people with advanced or metastatic HR+/HER2- breast cancer who haven't had prior treatment for advanced disease. The goal is to see if the new combo works better at d…
Phase: PHASE3 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Healthy volunteers needed to test drug interactions
Knowledge-focused Not yet recruitingThis study looks at how the body handles the experimental drug BGB-58067 when taken with two common medicines that change liver enzyme activity. Thirty healthy adults will receive BGB-58067 with either phenytoin (an enzyme booster) or itraconazole (an enzyme blocker). The goal is…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Knowledge-focused
Last updated May 17, 2026 11:35 UTC